Juan de Villafranca
Juan de Villafranca is the executive president of the Mexican Association of Pharmaceutical Laboratories (Amelaf). He has been vocal about the challenges faced by Mexican pharmaceutical companies, particularly in light of recent accusations against foreign companies, especially those from India, for failing to deliver contracted medications. De Villafranca advocates for clearer rules in the bidding process for pharmaceuticals and emphasizes the importance of timely payments from the government, which he claims has significant debts to local companies.
Not in the pool (under ¢1).
Recent news mentions
Juan de Villafranca stated that the delivery of medications is ongoing, but payments from the government have not progressed.
Pese a adeudos, farmacéuticas deben de cumplir con la entrega de medicamentos
Mexico· 2025-10-08
Juan de Villafranca is the president of the Mexican Association of Pharmaceutical Laboratories who stated that they continue to deliver medications but are not receiving payments.
Alistan inhabilitar a farmacéuticas incumplidasMexico· 2025-10-08
Juan de Villafranca is the CEO of the Mexican Association of Pharmaceutical Laboratories (Amelaf) who criticized foreign companies for causing delays in medication delivery.
Choque entre farmacéuticas y gobierno: claves del desabasto de medicinasMexico· 2025-09-27
He is the executive president of the Asociación Mexicana de Laboratorios Farmacéuticos.
Farmacéutica de India vende con amparo… e incumpleMexico· 2025-09-26
Juan de Villafranca, the executive president of the Mexican Association of Pharmaceutical Laboratories, emphasized the need for clear rules in the bidding process for medications.
Acusan a farmacéuticas extranjeras de retrasosMexico· 2025-09-25